Related Experiment Video

Updated: Dec 22, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.5K

Back to the future-Are we ready for a randomized trial of surgical versus percutaneous revascularization in

Jason N Katz1

  • 1Department of Medicine, Division of Cardiology, Duke University, Durham, NC.

American Heart Journal
|May 4, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.0K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.2K

Related Experiment Videos

Last Updated: Dec 22, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.5K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.0K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.2K

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

431
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
431
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

821
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
821

Articles linked to this work by shared authors, journal, and citation graph.

Cardiogenic Shock Management: A Framework for Individualized Microaxial Flow Pump Support.

Circulation. Heart failure·2026

Frailty Patterns, Reversibility, and Outcomes With a Magnetically Levitated Left Ventricular Assist Device.

JACC. Heart failure·2026

Timing of Mechanical Circulatory Support and In-Hospital Mortality in Patients With Cardiogenic Shock.

Mayo Clinic proceedings·2026

The Society of Critical Care Cardiology-Rationale, blueprint, and lessons learned in the creation of a new multidisciplinary professional organization.

American heart journal·2026

Clinical Characteristics and Outcomes of Older Patients Admitted to the Cardiac Intensive Care Unit.

JACC. Advances·2026

Associations Between Admission C-Reactive Protein and In-Hospital Mortality Amongst Patients with Cardiogenic Shock.

European heart journal. Acute cardiovascular care·2026

Pulsed field ablation with Renal denervation for persistent Atrial fibrIllation: Rationale and design of the PRAISE-AF randomized trial.

American heart journal·2026

Design and Rationale of the CLASP II TR Randomized Trial for Severe Tricuspid Regurgitation.

American heart journal·2026

Sex-based differences in mortality and prognostic factors for infective endocarditis: insights from a retrospective cohort of 519 patients.

American heart journal·2026

Design and rationale of the Urine Sodium-directed Diuretic Adjustment Strategy in Heart Failure (US-DASH) trial.

American heart journal·2026

Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3).

American heart journal·2026

Design and rationale of the TANGO2 trial: A randomized controlled non-inferiority trial of bystander compression-only CPR versus standard CPR in out-of-hospital cardiac arrest.

American heart journal·2026

Single-lumen tube cuff tamponade and dynamic positioning for bronchoscopy-associated massive airway hemorrhage: a case series.

Journal of thoracic disease·2026

Associated factors for in-hospital mortality in patients with fulminant myocarditis: a systematic review and meta-analysis.

Frontiers in cardiovascular medicine·2026

Glucagon-like Peptide-1-based and Emerging Cardiometabolic Therapies in Heart Failure with Preserved Ejection Fraction: Linking Molecular Mechanisms to Clinical Outcomes.

Cardiac failure review·2026

Acute-Onset Iron Overload Cardiomyopathy in Diamond-Blackfan Anaemia: A Case Report of Rapid Ejection Fraction Decline.

Cureus·2026

Predictive value of combined estimated plasma volume status and neutrophil-to-lymphocyte ratio for cardiovascular mortality in patients with acute myocardial infarction with heart failure.

Frontiers in cardiovascular medicine·2026

Concealed right upper lobe pulmonary venous variants on 3D-CTBA: morphological characterization and surgical implications.

Frontiers in medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us